{"name":"Barts & The London NHS Trust","slug":"barts-the-london-nhs-trust","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"DMARD","genericName":"DMARD","slug":"dmard","indication":"Other","status":"marketed"},{"name":"Envarsus","genericName":"Envarsus","slug":"envarsus","indication":"Other","status":"marketed"},{"name":"Administration of paracetamol","genericName":"Administration of paracetamol","slug":"administration-of-paracetamol","indication":"Other","status":"marketed"},{"name":"Adoport","genericName":"Adoport","slug":"adoport","indication":"Other","status":"discontinued"},{"name":"Combined Depo-Medrone and Lidocaine","genericName":"Combined Depo-Medrone and Lidocaine","slug":"combined-depo-medrone-and-lidocaine","indication":"Other","status":"marketed"},{"name":"Ergocalciferol (Vitamin D)","genericName":"Ergocalciferol (Vitamin D)","slug":"ergocalciferol-vitamin-d","indication":"Vitamin D deficiency","status":"marketed"},{"name":"Migliol Placebo Oil","genericName":"Migliol Placebo Oil","slug":"migliol-placebo-oil","indication":"Placebo control in clinical trials","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Carboplatin AUC-10","genericName":"Carboplatin AUC-10","slug":"carboplatin-auc-10","indication":"Ovarian cancer","status":"phase_2"},{"name":"Paclitaxel protein bound","genericName":"Paclitaxel protein bound","slug":"paclitaxel-protein-bound","indication":"Metastatic breast cancer","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"COVID-19 exposure","genericName":"COVID-19 exposure","slug":"covid-19-exposure","indication":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus","status":"phase_2"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Darbepoetin alpha","genericName":"Darbepoetin alpha","slug":"darbepoetin-alpha","indication":"Anemia associated with chronic kidney disease","status":"phase_3"}]}],"pipeline":[{"name":"DMARD","genericName":"DMARD","slug":"dmard","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Envarsus","genericName":"Envarsus","slug":"envarsus","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Administration of paracetamol","genericName":"Administration of paracetamol","slug":"administration-of-paracetamol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Adoport","genericName":"Adoport","slug":"adoport","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"COVID-19 exposure","genericName":"COVID-19 exposure","slug":"covid-19-exposure","phase":"phase_2","mechanism":"This drug aims to stimulate the immune system to fight COVID-19 infection.","indications":["Prevention of COVID-19 disease caused by SARS-CoV-2 virus"],"catalyst":""},{"name":"Carboplatin AUC-10","genericName":"Carboplatin AUC-10","slug":"carboplatin-auc-10","phase":"phase_2","mechanism":"Alkylating agent that forms platinum-DNA adducts, inhibiting DNA replication and transcription.","indications":["Ovarian cancer","Breast cancer","Lung cancer"],"catalyst":""},{"name":"Combined Depo-Medrone and Lidocaine","genericName":"Combined Depo-Medrone and Lidocaine","slug":"combined-depo-medrone-and-lidocaine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Darbepoetin alpha","genericName":"Darbepoetin alpha","slug":"darbepoetin-alpha","phase":"phase_3","mechanism":"Darbepoetin alpha is an erythropoiesis-stimulating agent that binds to the erythropoietin receptor to stimulate red blood cell production.","indications":["Anemia associated with chronic kidney disease","Anemia in patients with non-myeloid malignancies receiving chemotherapy","Anemia of chronic disease"],"catalyst":""},{"name":"Ergocalciferol (Vitamin D)","genericName":"Ergocalciferol (Vitamin D)","slug":"ergocalciferol-vitamin-d","phase":"marketed","mechanism":"Ergocalciferol is a form of vitamin D that is converted in the body to its active metabolite, which regulates calcium and phosphate absorption and homeostasis.","indications":["Vitamin D deficiency","Hypocalcemia","Hypoparathyroidism","Osteomalacia","Rickets"],"catalyst":""},{"name":"Migliol Placebo Oil","genericName":"Migliol Placebo Oil","slug":"migliol-placebo-oil","phase":"phase_3","mechanism":"Migliol is a medium-chain triglyceride oil used as a placebo or inert control vehicle in clinical trials.","indications":["Placebo control in clinical trials"],"catalyst":""},{"name":"Paclitaxel protein bound","genericName":"Paclitaxel protein bound","slug":"paclitaxel-protein-bound","phase":"marketed","mechanism":"Paclitaxel protein-bound stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and halting cell division in cancer cells.","indications":["Metastatic breast cancer","Non-small cell lung cancer","Pancreatic cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQbWxveXkxTENNaGRJUUJ4Q1JNc2lhNGxoWUFGOXpzN194aFNrQmpVeVJjd3N2U0lmalI5VzFEVHdUYi1jT2h2T3hLOENwclY3aHJ3cUI3WkRDWmU0S0x5QlZyTXJ2MHNfbnZzajhkcU5MX0dpSnVSMjlraWRIMjlNOWtKRFV4SFdKeGxEdG5iWkFiclhNRjlEU1lkeEtiLWJVZGFDUFh3SzZycnRpR240aDdvb0VFS0M4TGNN?oc=5","date":"2026-01-13","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Community pharmacy cholesterol testing pilot expands across east London - The Pharmaceutical Journal","headline":"Community pharmacy cholesterol testing pilot expands across east London","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5KZzdsLWx6bUdFRmZjVUZPSGd4N005S0dGeFBOMkVLdWt0eDhELUNXNVVyZFFuT1RUUXNuYzB2cFdkR2ExNkxKZ3pPZ2k1VndJa0JFeGs4NUZFajFvYlhqdThpUHlJRU0?oc=5","date":"2025-12-05","type":"pipeline","source":"Pharmacy Business","summary":"Barts Health rolls out cholesterol-lowering jabs in community pharmacies - Pharmacy Business","headline":"Barts Health rolls out cholesterol-lowering jabs in community pharmacies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNZ1N3a3RuY1RuNktZaWp1dGFLNUo3dkVYMm8zN2RTNExLUVpKQ01KTmhmV1dybk8zQmVXREM4MlFRTEYwMGdZQlpjZF93anJsVEdXMEQtY3JuWXVfbFRIaHlBTGRfbXNBcGpZY2hBbVJnR0xXc3VZdTJxaVFUYl9oNUhMazMxMnN5b0NMa1NwenBaYlM1WXpsNzdIQm1hdXpEd3NrR0pyU2NId01SZ3ZETTVacXpBSnUzTkhFeEFhanBURnZvSVBab3JxVGVYLUdJR0lSb0l1U1U?oc=5","date":"2025-12-04","type":"pipeline","source":"Chemist+Druggist","summary":"NHS trust pilots ‘cholesterol-lowering’ injections in pharmacies - Chemist+Druggist","headline":"NHS trust pilots ‘cholesterol-lowering’ injections in pharmacies - Chemist+Druggist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE04LUtaREtDekpnTDNUODMzQ3VJdnlRMnlIUW5KQl9rYnRObnRnNTNDNnJXWDItZWVFZlVxUUlDaGNKWmRVdFFEczByNGczSUtTaVNlSVIwZVRwR08yRDFiM19aa2IwaGZDZEg0MmNpcWhGRnZ1WFBNNHZKRQ?oc=5","date":"2025-11-25","type":"pipeline","source":"pharmaphorum","summary":"£800m life sciences cluster opens in London - pharmaphorum","headline":"£800m life sciences cluster opens in London","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPRmdIbGRUQkFWRmlFMnh3bnpyMzRsNVQ1cGhMQXJ1alltYkt4YlF3UGx4bTJnSUZicGtKUEdhRFAyamhRbnpSVmxWbW9ueUxwT2hVZFlDTGhRQUptc1BPLUJJSE1jTTctVlNYSF9USkxCLVRJaVpHSTYzeXV2RUROR3g5SUtoV1hBQi1CTzM1c29ZX1pOMGIwbVNpbjhRbjRJbWd3bU96SXFWenVjZVR4M1ZGa2hGTHowM1N2M0hCbGZWRThXVkpGLUtYakpWQUNxM0ZUZWRsSQ?oc=5","date":"2025-09-16","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Putting the spotlight back on haemoglobinopathies: the emergence of specialist pharmacists - The Pharmaceutical Journal","headline":"Putting the spotlight back on haemoglobinopathies: the emergence of specialist pharmacists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9ES2ZieU9tT29mSGxqN21JSERjYnd3dmY4YnpDVHZlcDJHZ1FQMHlhOTFuYmEwZFV0WnFTbEpsRHdNamg0UEI3b3p6X2o3MUE5TlZRc3ZldVByd3pycEtDSFNVaW1MSUNiLWg3NDdYYnN2UjhOOEpiWl9UQQ?oc=5","date":"2025-09-05","type":"trial","source":"thorax.bmj.com","summary":"Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation - thorax.bmj.com","headline":"Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQNkJ4TVRocjQtWmN4ME5TbC1JYVV2U3hSREZ6SGJPNkhOazF2WTFxRWFsZ01kcXpfLWhvSVJ1a1JOejVtZEZrNUMwckp5QUw0Z3NIUTRjNVprUVJNaHVObkpXRjlvYWJfUVc0U0dxT3dodm5ZUWRGWDRNcVREb29zZUlreEpmQ1BGRFpqdWRhQ3Z5Zm1rMFV5SmJYRVFMQk9DV2JUSmtMMU41dHliNmc?oc=5","date":"2025-08-19","type":"pipeline","source":"Pharmacy Magazine","summary":"East London pharmacies pilot rapid cholesterol testing - Pharmacy Magazine","headline":"East London pharmacies pilot rapid cholesterol testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQVUNFMVNTLUpiWkg4NEgwWlRqVmVoV1prYmloOUZKOUFxVFM2c2ZZZWdGa1MwLWsyd2tRQnhmMXQtcnBYZlFCajZxOEozTENfZ3luSjRtQ2lTaDRmS01ZZ0NPaG81VDdsdExqT1lkb0x6cGNPWE5MaW5rREtmMzVVLXlRVUtLc0R2cEhJVGZzQQ?oc=5","date":"2025-06-02","type":"pipeline","source":"PharmaTimes","summary":"NICE recommends mirikizumab for Crohn’s disease treatment - PharmaTimes","headline":"NICE recommends mirikizumab for Crohn’s disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPaG1TalUzRGRDLVRJalNMR0s0blFrR1ZzX191eUsyRmZxSnFDa2daUzFWbEZlRUVWeGZSQjU0QTR4bDdNMGNuS0NQUFlQelVoNmRfTDdQZGFhZU9MWTVIaFpYRjVxWDY4c0JUWElxa2Rzb1d1WkhwSzY5R1FXaXBqbEtsWU9yWjdfS3FRaDR4UTJxdmNCUlp1ZUFWaTdiSTR0bGZBcTJwOW5JSEtKRTRtaFRCYWRnaWZUelNjaGtnelBQX0Z6TXZKS3VaNlBMZ3AwMG85dTJrbkk0cmlkbENHcW9OVQ?oc=5","date":"2025-05-08","type":"pipeline","source":"Hospital Pharmacy Europe","summary":"The role of pharmacists in supporting transgender and gender-diverse patients with cancer - Hospital Pharmacy Europe","headline":"The role of pharmacists in supporting transgender and gender-diverse patients with cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxOUEcxMFJZenRXRFQwSFR6UklTdWFVY2dpV3JyMjZnc2Q2X3kxWTVVUG1HNXo5b3VTNGZEdGxRNTg1T29lVHBVajJaQ3dLbVVpZnJiN1JudThMcWxESzZJWWdNSV9WX0I2X1BsTk81T1NRck9ScUZ3T2FtaHFDTE81eHBYY2RtSVdDOWJBRDdZZVl0dmhSOVJHVmtSamNkNVRCX1hLS3JXSWNtVUtvSUI2d0djamM1TnhWa0ZWLUJoQnUyMzBqU3VkVzRBSWdwZHZXUWo3V0VKcjlNdmc5dmlYMzV4RnllTVJYMHp1T1JLb1JjaEkwYjg0ODUtSUppekUyYVNYTA?oc=5","date":"2025-02-11","type":"pipeline","source":"Queen Mary University of London","summary":"Queen Mary University of London co-leads £43.6m initiative to accelerate AI-powered cancer breakthroughs - Queen Mary University of London","headline":"Queen Mary University of London co-leads £43.6m initiative to accelerate AI-powered cancer breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNODBHZ3FVT3ZiU2tWNHhmSm45N2VYM1BxNVRaSEFpMzg3dTViaW5DS2hYeEdqaWg0T1JwNlU5djVIOW9NY0s1bm51VTE1cXNFSGRXNFczNXZodDRxUmtrOXdPeXBtUURheGVReGxCWDk2ZnRJV2IzNUtDOGJPa0pFQVlJcXB1b3ZTN1F3eURFSnJ0TmNqNjlYVUFVWDdXbUxI?oc=5","date":"2024-10-24","type":"pipeline","source":"BMJ Group","summary":"Investigation finds “unexplained” millions in drug industry payments to the NHS - BMJ Group","headline":"Investigation finds “unexplained” millions in drug industry payments to the NHS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQMndaSGRjaUJfbjMxYVM0V1hNOEZRcnFwbGtWTUw2S2QxdlVkYW9SYVVEZm9wRnpYTnJ5ZktqcnBwMUJudXV1Qno2S2YzWDZqTzRHUkh4ODJRMlN5dVJLaHhzT1Bxa3RIbWdkeUpWSTZWekEzY1JlZFJZekpydTM0emUwOWc2cGVjNjByQ0VMN3VqMlU4?oc=5","date":"2021-09-28","type":"pipeline","source":"pharmaphorum","summary":"Barts Health NHS Trust launches app for cognitively impaired - pharmaphorum","headline":"Barts Health NHS Trust launches app for cognitively impaired","sentiment":"neutral"}],"patents":[],"drugCount":11,"phaseCounts":{"marketed":6,"discontinued":1,"phase_2":2,"phase_3":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}